Login





Genetica e omiche / Modelli sperimentali / Trasduzione del segnale

POST-TRANSLATIONAL MODIFICATIONS OF ALBUMIN IN END-STAGE RENAL DISEASE

poster

Background

The aim of this study is to detect eventual modification in the expression of plasma proteins and/or post-translational modifications of their structure in end-stage renal disease.

Patients and Methods

Serum samples from 19 adult patients treated by maintenance hemodialysis were analyzed by using SDS-PAGE and  two-dimensional electrophoresis (2DE). Spots of interest were identified by mass spectrometry analysis. Moreover, the 2DE maps were incubated with a human antialbumin polyclonal antibody.

Results

SDS-PAGE gels, 2DE maps and MALDI-TOF analysis indicated the over-expression, in sera from patients, of low-molecular weight proteins (LMWP). Unexpectedly, other 15 spots with estimated Mr 12.5-29 kDa from 2DE maps of 6 patients were identified as fragments of albumin. 2-D immunoblotting of sera from 12 other patients detected numerous albumin fragments. Oxidative stress and inflammation are markedly increased in ESRD patients. Oxidative stress can affect the structure of albumin and increase the susceptibility of the molecule to the activity of proteolytic enzymes, thus justifying  the presence of albumin fragments in the serum of ESRD patients. The clinical significance of albumin fragmentation  in the pathogenesis of uremic syndrome remains uncertain. However, it is possible that antioxidant capacity, binding and transport functions of albumin be affected by post-translational modifications of the molecule. It is important to note that proteomic techniques allowed to highlight these post-translational modifications of albumin, which remained undetected hitherto hidden, using standard laboratory techniques.

Conclusions

A relevant amount of fragments of albumin is detectable in the serum of maintenance hemodialysis patients. Uremia seems to facilitate the fragmentation of albumin and/or the retention in the blood of albumin fragments.

release  1
pubblicata il  25 settembre 2012 
da Carlo Donadio, Danika Tognotti, Elena Donadio
(Departimento di Medicina Interna, Unità di Nefrologia. Università di Pisa, Pisa)
Parole chiave: end-stage
Non sono presenti commenti
Figure

Per inserire una domanda, segnalare la tua esperienza, un tuo commento o una richiesta di precisazione fai il login con il tuo nome utente e password.

Se non lo sei ancora puoi registrati partendo da qui.

WebPoster

Link utili

Realizzazione: Tesi S.p.A.

 Per assistenza contattare: Claudia Ingrassia, Tesi S.p.A.
0172 476301 — claudia.ingrassia@gruppotesi.com